enow.com Web Search

  1. Ads

    related to: lab markers for lung cancer test and diagnosis treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Lung cancer screening - Wikipedia

    en.wikipedia.org/wiki/Lung_cancer_screening

    Chest x-ray screenings were found to detect 6 times as many new cancers as sputum tests, proving the disutility of sputum tests in lung cancer screening. [17] However, the results from the Mayo Lung Project and the Hopkins and Memorial Sloan-Kettering studies were eventually discredited, due to failure to account for lead time and length time ...

  3. Tumor marker - Wikipedia

    en.wikipedia.org/wiki/Tumor_marker

    Tumor markers can be molecules that are produced in higher amounts by cancer cells than normal cells, but can also be produced by other cells from a reaction with the cancer. [2] The markers can't be used to give patients a diagnosis but can be compared with the result of other tests like biopsy or imaging. [2]

  4. Cancer biomarker - Wikipedia

    en.wikipedia.org/wiki/Cancer_biomarker

    Genetic, [1] epigenetic, [2] proteomic, [3] glycomic, [4] and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. [5] Cancer is a disease that affects society at a world-wide level.

  5. Imaging biomarker - Wikipedia

    en.wikipedia.org/wiki/Imaging_biomarker

    In medicine, an imaging biomarker is a feature of an image relevant to a patient's diagnosis. For example, a number of biomarkers are frequently used to determine risk of lung cancer. First, a simple lesion in the lung detected by X-ray, CT, or MRI can lead to the suspicion of a neoplasm. The lesion itself serves as a biomarker, but the minute ...

  6. Treatment of lung cancer - Wikipedia

    en.wikipedia.org/wiki/Treatment_of_lung_cancer

    Chemotherapy for NSCLC usually includes combination of two drugs (chemotherapy doublet), with one of the agents is cisplatin or carboplatin. In 2002, Schiller at al. published in the New England Journal of Medicine, a study that compared four chemotherapy regimens for advanced NSCLC, cisplatin and paclitaxel, cisplatin and gemcitabine, cisplatin and docetaxel, and carboplatin and paclitaxel. [14]

  7. Pro-gastrin-releasing-peptide - Wikipedia

    en.wikipedia.org/wiki/Pro-Gastrin-Releasing-Peptide

    As early as 1994, research on Pro-GRP as a biomarker for small-cell lung carcinoma began. [12] Because of the very short half-life of GRP (2 minutes), the Pro-GRP is used for measurements and analysis. Since then, Pro-GRP has been used as a tumor marker for patients with small-cell lung carcinoma in limited and extended stages. [13]

  1. Ads

    related to: lab markers for lung cancer test and diagnosis treatment